Vif-derived peptide (Yissum)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVif-derived peptide (Yissum)
Drug Alias NameA3G protein inhibitor (Yissum)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAPOBEC3G deaminase inhibitors
TargetsAPOBEC3G deaminase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYissum Research Development Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYissum Research Development Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A